Cannabiz editor-at-large Rhys Cohen takes a look at the small print in the Department of Health’s consultation paper on reforms to medicinal cannabis manufacturing, labelling and packaging.

The Department of Health has commenced a consultation process addressing several significant regulatory challenges facing Australia’s medicinal cannabis industry. At a very general level, these issues are:

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

Vel turpis nunc eget lorem dolor sed. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. Nisl nunc mi ipsum faucibus vitae.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Vel turpis nunc eget lorem dolor sed. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. Nisl nunc mi ipsum faucibus vitae.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh.
Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh.

Rhys Cohen

As well as being editor-at-large at Cannabiz, Rhys is the director of Cannabis Consulting Australia, which provides commercial consulting services to various domestic and international cannabis companies....

Join the Conversation

2 Comments

  1. It would appear the regulators are not well informed about cannabis production, cultivation and common practice. A simple trip to North America, Israel or even some European countries might elucidate their strategy here. An even better and possibly more business friendly option could be to lower the boundaries to Australian companies to utilise the channels available to international firms? A cannabis tracking and licensing system from local producers through to patient could aid with traceability in these channels.

  2. Or you could just buy some weed – Australian regulators tie themselves in regulations so that others can then find the loopholes which in turn creates more complicated regulations with loopholes – meanwhile people just give up and buy from the black or grey market whether it be for medicinal or recreational – it’s like a stoner episode of Yes Minister gone wrong